Type 2 Diabetes

Decreased vaccine efficacy tied to uptick in COVID cases, Israeli study finds … Newer glucose reducing drugs not linked to fracture risk in seniors with type 2 diabetes: study … Pitfalls of telehealth...

Participants taking alendronate were 36% less likely to have new-onset type 2 diabetes than their peers who did not take the drug, according to a large, 10-year study in Denmark.

Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.

Abnormal nighttime blood pressure dips can double the odds of death for patients with diabetes, a long-term study has found. Clinicians should regularly look for and treat the problem, investigators say.

Remission defined as HbA1c <6.5 percent for at least three months after cessation of glucose-lowering pharmacotherapy

Secondary analysis of randomized trial shows no difference in progression of KDIGO risk scores with daily vitamin D versus placebo

U.S. reportedly sets time to renew COVID shots at 8 months, while Pfizer releases trial data in bid to expand booster shot access … Patients taking type 2 diabetes drugs may have fewer Alzheimer’s...

The high price tag and lack of coverage for high-performing anti-obesity drug Wegovy begs the question of what the benefits of weight loss are worth to insurers and patients.

Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.

(HealthDay News) — The use of certain classes of diabetes medications prior to severe COVID-19 infection is associated with lower mortality in patients with diabetes, according to a study published online...